Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817
- Paz-Ares, L.G.
- Ciuleanu, T.-E.
- Pluzanski, A.
- Lee, J.-S.
- Gainor, J.F.
- Otterson, G.A.
- Audigier-Valette, C.
- Ready, N.
- Schenker, M.
- Linardou, H.
- Caro, R.B.
- Provencio, M.
- Zurawski, B.
- Lee, K.H.
- Kim, S.-W.
- Caserta, C.
- Ramalingam, S.S.
- Spigel, D.R.
- Brahmer, J.R.
- Reck, M.
- O'Byrne, K.J.
- Girard, N.
- Popat, S.
- Peters, S.
- Memaj, A.
- Nathan, F.
- Aanur, N.
- Borghaei, H.
- Montrer des auteurs +
ISSN: 1556-1380, 1556-0864
Année de publication: 2023
Volumen: 18
Número: 1
Pages: 79-92
Type: Article